Olfactory stimulation prevents apnea in premature newborns

Pediatrics

Volumn 115, Issue 1, 2005, Pages 83-88

  Marlier, Luc ^a,b   Gaugler, Christophe ^b   Messer, Jean ^b  

^a CNRS   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Apnea; Health; Incubator; Neonatal adaptation; Olfaction; Premature newborn

Indexed keywords

CAFFEINE; DOXAPRAM; CENTRAL STIMULANT AGENT; RESPIRATORY TRACT AGENT;

APNEA; ARTICLE; BRADYCARDIA; BREATHING RATE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; HYPOXIA; MALE; NEWBORN; ODOR; PREMATURITY; PRIORITY JOURNAL; RECURRENT DISEASE; SENSORY STIMULATION; SMELLING; TREATMENT FAILURE; AROMATHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; MULTIMODALITY CANCER THERAPY; STIMULATION;

APNEA; AROMATHERAPY; BRADYCARDIA; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COMBINED MODALITY THERAPY; DOXAPRAM; DRUG THERAPY, COMBINATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; ODORS; PHYSICAL STIMULATION; RESPIRATORY SYSTEM AGENTS; SMELL;

EID: 16844371507     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-0865     Document Type: Article

References (52)

1. Henderson-Smart DJ. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aust Paediatr J. 1981;17:273-276
2. Miller MJ, Martin RJ. Apnea of prematurity. Clin Perinatol. 1992;19:789-808
3. Henderson-Smart DJ, Butcher-Puech MC, Edwards DA. Incidence and mechanism of bradycardia during apnoea in preterm infants. Arch Dis Child. 1986;61:227-232
4. Martin RJ, Fanaroff AA. Neonatal apnea, bradycardia, or desaturation: does it matter? J Pediatr. 1998;132:758-759
5. Perlman JM, Volpe JJ. Episodes of apnea and bradycardia in the preterm newborn: impact on cerebral circulation. Pediatrics. 1985;76:333-338
6. Livera LN, Spencer SA, Thorniley MS, Wickramasinghe YA, Rolfe P. Effects of hypoxaemia and bradycardia on neonatal cerebral haemodynamics. Arch Dis Child. 1991;66:376-380
7. Ramanathan R, Corwin M, Hunt CE, et al. Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS. JAMA. 2001;285:2199-2207
8. Payer C, Urlesberger B, Pauger M, Müller W. Apnea associated with hypoxia in preterm infants: impact on cerebral blood volume. Brain Dev. 2003;25:25-31
9. Baird TM. Clinical correlates, natural history and outcome of neonatal apnoea. Semin Neonatol. 2004;9:205-211
10. Lucey JF. The xanthine treatment of apnea of prematurity. Pediatrics. 1975;55:584-586
11. Bairam A, Boutroy M-J, Badonnel Y, Vert P. Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant. J Pediatr. 1987;110:636-639
12. Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA. Caffeine citrate for the treatment of apnea of prematurity: a doubleblind, placebo-controlled study. Pharmacotherapy. 2000;20:644-652
13. Alpan G, Eyal F, Sagi E, Springer C, Patz D, Goder K. Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline. J Pediatr. 1984;104:634-637
14. Sagi E, Eyal F, Alpan G, Patz D, Arad I. Idiopathic apnoea of prematurity treated with doxapram and aminophylline. Arch Dis Child. 1984;59:281-283
15. Barrington KJ, Finer NN, Peters KL, Barton J. Physiologic effects of doxapram in idiopathic apnea of prematurity. J Pediatr. 1986;108:125-129
16. Gerhardt T, McCarthy J, Bancalari E. Effect of aminophylline on respiratory center activity and metabolic rate in premature infants with idiopathic apnea. Pediatrics. 1979;63:537-542
17. Tay-Uyboco J, Kwiatkowski K, Cates DB, Hasan SU, Rigatto H. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity. Biol Neonate. 1991;59:190-200
18. Hoecker C, Nelle M, Poeschl J, Beedgen B, Linderkamp O. Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics. 2002;105:784-787
19. Barrington KJ, Finer NN, Torok-Both G, Jamali F, Coutts RT. Doseresponse relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity. Pediatrics. 1987;80:22-27
20. Marlier L, Schaal B, Gaugler C, Messer J. Olfaction in premature human newborns: detection and discrimination abilities two months before gestational term. Chemical Signals Vertebr. 2001;9:205-209
21. Marlier L, Gaugler C, Soussignan R, Schaal B, Messer J. Premature newborns differentiate the affective value of odours during sleep. J Matern Fetal Neonatal Med. 2002;11(suppl 1):64
22. Gabriel M, Albani M, Schulte FJ. Apneic spells and sleep states in preterm infants. Pediatrics. 1976;57:142-147
23. Lehtonen L, Martin RJ. Ontogeny of sleep and awake states in relation to breathing in preterm infants. Semin Neonatol. 2004;9:229-238
24. Goubet N, Rattaz C, Pierrat V, Alléman E, Bullinger A, Lequien P. Olfactory familiarization and discrimination in preterm and full-term newborns. Infancy. 2002;3:53-75
25. Marlier L, Gaugler C, Soussignan R, Schaal B, Messer J. Early discrimination of odour hedonics in preterm newborns [abstract]. Chem Senses. 2003;28:74
26. Keppel G. In: Jenkins JJ, ed. Design and Analysis: A Researcher's Handbook. Englewood Cliffs, NJ: Prentice-Hall; 1973
27. Ludvigson HW, Rottman TR. Effects of ambient odors of lavender and cloves on cognition, memory, affect and mood. Chem Senses. 1989;14:525-536
28. Knasko SC, Gilbert AN, Sabini J. Emotional state, physical well-being, and performance in the presence of feigned ambient odor. J Appl Soc Psychol. 1990;20:1345-1357
29. Knasko SC. Ambient odor's effect on creativity, mood, and perceived health. Chem Senses. 1992;17:27-35
30. Brauchli P, Ruegg PB, Etzweiler F, Zeier H. Electrocortical and autonomic alteration by administration of a pleasant and an unpleasant odor. Chem Senses. 1995;20:505-515
31. Alaoui-Ismaïli O, Vernet-Maury E, Dittmar A, Delhomme G, Chanel J. Odor hedonics: connection with emotional response estimated by autonomic parameters. Chem Senses. 1997;22:237-248
32. Bensafi M, Rouby C, Fraget V, Bertrand B, Vigouroux M, Holley A. Influence of affective and cognitive judgments on autonomic parameters during inhalation of pleasant and unpleasant odors in humans. Neurosci Lett. 2002;319:162-166
33. Soussignan R, Schaal B, Marlier L, Jiang T. Facial and autonomic responses to biological and artificial olfactory stimuli in human neonates: re-examining early hedonic discrimination of odors. Physiol Behav. 1997;62:745-758
34. Bartocci M, Winberg J, Ruggiero C, Bergqvist LL, Serra G, Lagercrantz H. Activation of olfactory cortex in newborn infants after odor stimulation: a functional near-infrared spectroscopy study. Pediatr Res. 2000;48:18-23
35. VanReempts PJ, Wouters A, DeCock W, VanAcker KJ. Stress responses to tilting and odor stimulus in preterm neonates after intrauterine conditions associated with chronic stress. Physiol Behav. 1997;61:419-424
36. Bartocci M, Winberg J, Papendieck G, Mustica T, Serra G, Lagercrantz H. Cerebral hemodynamic response to unpleasant odors in the preterm newborn measured by near-infrared spectroscopy. Pediatr Res. 2001;50:324-330
37. Martin GN. Olfactory remediation: current evidence and possible applications. Soc Sci Med. 1996;43:63-73
38. Ionasescu V. The relations between olfactory and vestibular sensory impulses and temporal lobe epilepsy. Acta Psychiatr Scand. 1961;36:415-420
39. Efron R. The effect of olfactory stimuli in arresting uncinate fits. Brain. 1956;79:267-281
40. Fox AW. Pharmaceutics. In: Fletcher AJ, Edwards LD, Fox AW, Stonier P, eds. Principles and Practice of Pharmaceutical Medicine. London, United Kingdom: Wiley; 2003
41. Pagliaro AM. Administrating drugs to infants, children, and adolescents. In: Pagliaro LA, Pagliaro AM, eds. Problems in Pediatric Drug Therapy. Washington, DC: American Pharmacologists Association; 2002:1-86
42. Astic L, Saucier D, Coulon P, Lafay F, Flamand A. The CVS strain of rabies virus as transneuronal tracer in the olfactory system of mice. Brain Res. 1993;619:146-156
43. Mellier D, Bezard S, Caston J. Explanatory studies on olfaction-pain intersensory connections [in French]. Enfance. 1997;1/1997:98-111
44. Sullivan RM, Toubas P. Clinical usefulness of maternal odor in newborns: soothing and feeding preparatory responses. Biol Neonate. 1998;74:402-408
45. Goubet N, Rattaz C, Pierrat V, Bullinger A, Lequien P. Olfactory experience mediates response to pain in preterm newborns. Dev Psychobiol. 2003;42:171-180
46. Soussignan R, Schaal B, Marlier L. Olfactory alliesthesia in human neonates: prandial state and stimulus familiarity modulate facial and autonomic responses to milk odors. Dev Psychobiol. 1999;35:3-14
47. Varendi H, Porter RH. Breast odour as the only maternal stimulus elicits crawling towards the odour source. Acta Paediatr. 2001;90:372-375
48. Marlier L, Schaal B. Human newborns prefer human milk: conspecific milk odor is attractive without postnatal exposure. Child Dev. 2005; In press
49. Garcia AP, White-Traut R. Preterm infant's responses to taste/smell and tactile stimulation during an apneic episode. J Pediatr Nurs. 1993;8:245-252
50. Als H, Duffy F, McAnulty G. Behavioral differences between preterm and full-term newborns as measured with the APIB system scores. Infant Behav Dev. 1988;11:305-318
51. Lester B, Boukydis C, La Gasse L. Cardiorespiratory reactivity during the Brazelton Scale in term and preterm infants. J Pediatr Psychol. 1996;21:771-783
52. Graven SN, Bowen FW, Brooten D, et al. The high-risk infant environment. Part 1. The role of the neonatal intensive care unit in the outcome of high-risk infants. J Perinatol. 1992;12:164-172